A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo Pen

Completed · Phase 1

Conditions studied: Postmenopausal Osteoporosis

In brief

The purpose of this study is to determine which of two delivery methods of Parathyroid Hormone (PTH) is preferred by patients after 14 days of use for each.

Key facts

Study ID

NCT02478879

Run by

Zosano Pharma Corporation

People needed

24

Starts

2015-06-01

Expected to finish

2015-12-01

Last updated by the study team

2016-08-23

Who can join

Age: 55 and older, up to 85. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Postmenopausal with prior diagnosis of osteoporosis

You may not qualify if…

• Significant health issue
• previous use of teriparatide
• History of Paget's disease

Where it is running

• Covance Daytona Beach Clinical Research Unit — Daytona Beach, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.